Your browser doesn't support javascript.
loading
A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice.
Ma, Qianqian; Hu, Xiaozhi; Liu, Fangyu; Cao, Zhonglian; Han, Lei; Zhou, Kaicheng; Bai, Yu; Zhang, Yuting; Nan, Yanyang; Lv, Qianying; Rao, Jia; Wu, Tao; Yang, Xue; He, Haidong; Ju, Dianwen; Xu, Hong.
Affiliation
  • Ma Q; Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
  • Hu X; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
  • Liu F; Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Cao Z; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
  • Han L; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
  • Zhou K; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
  • Bai Y; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
  • Zhang Y; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
  • Nan Y; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
  • Lv Q; Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
  • Rao J; Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
  • Wu T; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
  • Yang X; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
  • He H; Department of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.
  • Ju D; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
  • Xu H; Department of Nephrology, Minhang Hospital, Fudan University, Shanghai, China.
Front Immunol ; 13: 1011442, 2022.
Article in En | MEDLINE | ID: mdl-36544775
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Diabetic Nephropathies Limits: Animals Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus / Diabetic Nephropathies Limits: Animals Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: China